Sustainability at Biocon
Research Services (Syngene): Overview
Offering integrated research, development & manufacturing services for small & large
molecules, antibody-drug conjugates & oligonucleotides backed by best-in-class
bioinformatic services
World-class R&D and manufacturing infrastructure spread over 2 million square feet
Audited successfully by US FDA, EMA, AAALAC and major life sciences partners
Talented scientific & techno-commercial teams, led by experienced management, moving
beyond cost arbitrage to innovation; 5000+ talented team of scientists, incl. ~500 PhDs
~420+ active marquee clients across multiple sectors
Strong track record of top-line growth with best-in-class EBITDA margins and Net Profit
margin
Listed in India on BSE and NSE in 2015
Biocon
26View entire presentation